This section explores the mechanisms through which HIF-1α impacts immunotherapy, focusing on its role in immune checkpoint regulation, modulation of tumor-infiltrating immune cells, resistance to immunotherapy, and potential therapeutic strategies targeting HIF-1α (Figure 2). This evidence concerns the gene HIF1A and neoplasm.